Cargando…
Kinetics of drug action in disease states: towards physiology-based pharmacodynamic (PBPD) models
Gerhard Levy started his investigations on the “Kinetics of Drug Action in Disease States” in the fall of 1980. The objective of his research was to study inter-individual variation in pharmacodynamics. To this end, theoretical concepts and experimental approaches were introduced, which enabled asse...
Autor principal: | Danhof, Meindert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582079/ https://www.ncbi.nlm.nih.gov/pubmed/26319673 http://dx.doi.org/10.1007/s10928-015-9437-x |
Ejemplares similares
-
Pharmacokinetic–Pharmacodynamic Modeling of the Effectiveness and Safety of Buprenorphine and Fentanyl in Rats
por: Yassen, Ashraf, et al.
Publicado: (2007) -
First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development
por: Strougo, Ashley, et al.
Publicado: (2012) -
Mechanism-Based Pharmacokinetic–Pharmacodynamic Modeling of the Dopamine D(2) Receptor Occupancy of Olanzapine in Rats
por: Johnson, Martin, et al.
Publicado: (2011) -
Genetic analysis of mecA gene and detection of homologue pbpD in Stahylococcus sciuri group
por: Calazans-Silva, Amanda C., et al.
Publicado: (2014) -
Pharmacokinetic-Pharmacodynamic Modeling of the D(2) and 5-HT(2A) Receptor Occupancy of Risperidone and Paliperidone in Rats
por: Kozielska, Magdalena, et al.
Publicado: (2012)